ASTRAZENECA PLC (AZN)
Clinical trial NCT06355934 updates: 1. completion date: 2026-09-30 → 2026-11-02 2. primary completion date: 2026-09-30 → 2026-11-02
Clinical trial NCT06355934 updates: 1. completion date: 2026-09-30 → 2026-11-02 2. primary completion date: 2026-09-30 → 2026-11-02
📉 **NEGATIVE** • Medium confidence analysis (66%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (22%) **Content type:** Clinical